Employees: 762
Size Advanced Enzyme Technologies (ADVENZYMES.NS) is an India Consumer Staples company (Food: Specialty/Candy) with a market value of $336M, the 1019th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹281.00 on 18 Nov 2026.
Performance Over six months the shares fell 27.3%, against -3.3% for the median peer and +3.8% for the India market (cap-weighted) — 5th lowest of 21 in its peer set.
Growth Revenue grew 10.3% over the last twelve months (peer median +4.1%); the operating margin is 24.9% (peer median 5.8%).
Valuation It trades at 17.7× forward earnings against a peer median of 17.9× (7th cheapest of 13).
Price implies For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +11 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.4 points below its cost of capital (16.0% WACC).
Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹7.80B | ₹7.45B | ₹6.37B | ₹6.23B | ₹5.40B |
| Revenue growth | — | +17% | +2% | +15% | — |
| Gross profit | ₹3.66B | ₹2.74B | ₹2.40B | ₹2.46B | ₹1.97B |
| EBITDA | ₹2.36B | ₹2.32B | ₹1.97B | ₹2.07B | ₹1.65B |
| Net income | ₹1.71B | ₹1.69B | ₹1.31B | ₹1.33B | ₹1.06B |
| Free cash flow | n/a | ₹1.20B | ₹1.15B | ₹1.09B | ₹1.08B |
| Capital expenditure | n/a | ₹524M | ₹348M | ₹473M | ₹382M |
| Total debt | ₹537M | ₹320M | ₹394M | ₹473M | ₹335M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ADVENZYMES.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +7.2% | -3.4% | 2nd highest of 21 |
| 6-month return | -27.3% | -3.3% | 5th lowest of 21 |
| Distance from 52-week high | -32.9% | -26.7% | 9th lowest of 21 |
| Revenue growth (TTM) | +10.3% | +4.1% | 8th highest of 21 |
| Operating margin | 24.9% | 5.8% | highest of 21 |
| Forward P/E | 17.7× | 17.9× | 7th cheapest of 13 |
| Growth the price implies (Req g, 7 yrs) | 19.2% | -1.5% | 5th most demanding of 14 |
| Growth delivered (Del g) | +8.3% | +3.8% | 4th highest of 14 |
| Hurdle (Req g minus delivered) | +10.9 pp | -3.2 pp | 4th most demanding of 14 |
| ROIC minus cost of capital | -3.4 pp | -0.8 pp | 6th lowest of 21 |
| EV / EBITDA | 11.0× | 7.0× | 5th most expensive of 14 |
| Net debt / EBITDA | -2.6× | 0.3× | 3rd least indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies ADVENZYMES.NS | India | $336M | -27% | +10% | 25% | 17.7× | 19.2% | +8.3% |
| Lam Soon (Hong Kong) 0411.HK | Hong Kong | $335M | +12% | +5% | 6% | n/a | n/a | n/a |
| Chen Ke Ming Food Manufacturing 002661.SZ | China | $325M | -22% | +1% | -4% | n/a | 20.1% | +1.9% |
| Gopal Snacks GOPAL.NS | India | $351M | -10% | +20% | 5% | 44.4× | n/a | n/a |
| KOIKE-YA 2226.T | Japan | $316M | +1% | +3% | 7% | n/a | n/a | n/a |
| Meito 2207.T | Japan | $364M | +18% | +3% | 3% | 12.9× | n/a | n/a |
| Tasty Bite Eatables TASTYBITE.NS | India | $304M | +50% | +11% | 5% | n/a | 52.0% | +7.3% |
| YEST 122640.KS | South Korea | $376M | -12% | +42% | 12% | 24.0× | 26.5% | +5.7% |
| Delfi P34.SI | Singapore | $301M | -37% | -2% | 7% | 9.8× | -14.4% | +4.2% |
| Fujicco 2908.T | Japan | $300M | +7% | -2% | 3% | 28.9× | n/a | n/a |
| Bonduelle SCA BON.PA | France | $299M | +5% | -1% | 4% | 8.2× | -2.9% | +0.2% |
| Gourmet Master 2723.TW | Taiwan | $380M | +11% | -10% | 8% | 12.0× | -8.5% | -1.7% |
| Kunshan Asia Aroma 301220.SZ | China | $380M | -45% | +13% | 6% | 22.9× | 9.6% | +12.4% |
| Tianshui Zhongxing Bio-Technology 002772.SZ | China | $383M | -52% | +12% | 14% | n/a | n/a | n/a |
| Qingdao Richen Food 603755.SS | China | $383M | -6% | +11% | 17% | 31.2× | 19.2% | +12.3% |
| WARABEYA NICHIYO 2918.T | Japan | $295M | 0% | +3% | 3% | 9.0× | -1.5% | +3.8% |
| Fujiya 2211.T | Japan | $391M | +2% | +6% | 1% | n/a | n/a | n/a |
| Chalkis Health Industry 000972.SZ | China | $393M | -10% | +17% | -52% | n/a | -6.9% | +89.3% |
| QAF Q01.SI | Singapore | $399M | -10% | 0% | 6% | n/a | -11.0% | +2.4% |
| Petpal Pet Nutrition Technology 300673.SZ | China | $403M | -31% | +2% | 6% | 41.4× | 6.0% | +1.6% |
| Ganso 603886.SS | China | $412M | -1% | +5% | 6% | 10.1× | -14.0% | -1.9% |